#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Immune thrombocytopenia Severe myoclonic epilepsy of infancy Leukocyte adhesion deficiency Cystic fibrosis respiratory infection suppression Osteomyelitis Anaemia Encephalitis autoimmune Obesity Pyoderma gangrenosum Non-Hodgkin's lymphoma Hereditary motor and sensory neuropathy Breast cancer Selective polysaccharide antibody deficiency Encephalopathy neonatal Hydrocephalus More trials…

    Learn about Rare Diseases

    Leiomyosarcoma recurrent – Basic Information Atypical haemolytic uraemic syndrome – Treatment Progressive supranuclear palsy – Basic Information Waldenstrom’s macroglobulinaemia recurrent – Basic Information Metachromatic leukodystrophy – Diagnostics Chondrosarcoma – Basic Information Waldenstrom’s macroglobulinaemia – Basic Information Lysosomal storage disorder – Diagnostics Encephalitis autoimmune – Treatment Skin angiosarcoma – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Irinotecan Hydrochloride MEGESTROL ACETATE Mk-1088 Phleum Pratense Gliclazide CEFTAROLINE FOSAMIL HAFNIUM OXIDE Heparin Dexketoprofen Norfloxacin Jnj-81241459 Fexofenadine Eteplirsen Ofatumumab Lisaftoclax Calcium Lactate Gluconate Metformin Hydrochloride Certolizumab Pegol Atuliflapon Imiquimod More therapies…

    Learn about Your Condition

    Metachromatic leukodystrophy Hypocalcaemia Femoral neck fracture Primary hypogonadism Nodal osteoarthritis Genital herpes Hypoalbuminaemia Heart transplant Urinary tract infection Cerebrovascular accident Hyperthyroidism Astrocytoma malignant Leiomyosarcoma recurrent Bipolar disorder Critical illness More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Parkinson’s disease

  • A study to test if BHV-8000 is effective and safe for adults with early Parkinson’s disease

    Not yet recruiting

    4 1 1
    Investigated Diseases:
    • Parkinson’s disease
    Investigated Drugs:
    • Ioflupane (123I)
    Austria Belgium Czechia France Germany Italy +4

  • Study of safinamide compared to placebo for pain relief in patients with Parkinson’s disease who experience motor fluctuations

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Parkinson’s disease
    Investigated Drugs:
    • Safinamide
    Italy

  • Study of serotonin system changes in early Parkinson’s disease using [11C]DASB and [11C]SB207145 PET imaging in people with SNCA gene mutations

    Not yet recruiting

    4 1 1
    Investigated Diseases:
    • Parkinson’s disease
    Investigated Drugs:
    • (1-(11C)METHYLPIPERIDIN-4-YL)METHYL 5-AMINO-6-CHLORO-1,4-BENZODIOXINE-8-CARBOXYLATE
    • 3-AMINO-4-[2-[[METHYL((111C)METHYL)AMINO]METHYL]PHENYL]SULFANYLBENZONITRILE
    France

  • Study on the Safety and Effects of LY3884961 for Patients with Parkinson’s Disease and a GBA1 Mutation

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Parkinson’s disease
    Investigated Drugs:
    • Adeno-Associated Viral Vector Serotype 9 Expressing Codon-Optimized Human Gba Gene
    The Netherlands

  • Study on the Safety and Effectiveness of NEU-411 for Patients with Early Parkinson’s Disease

    Not yet recruiting

    2 1
    Investigated Diseases:
    • Parkinson’s disease
    Italy Poland Spain

  • Study of [18F]MC225 to Assess P-glycoprotein Function in Patients with Alzheimer’s, Mild Cognitive Impairment, and Parkinson’s Disease

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Cerebral amyloid angiopathy
    • Parkinson’s disease
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • [18F]Mc225
    The Netherlands
Previous Page
1 … 3 4 5 6 7 … 9
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!